Immunotherapy Drugs - Global Market Outlook (2016-2022)

Immunotherapy Drugs - Global Market Outlook (2016-2022)

  • Published: September 2016
  • ID: SMRC15879

According to Stratistics MRC, the Global Immunotherapy Drugs market is accounted for $38.26 billion in 2015 and is expected to reach $97.47 billion by 2022 growing at a CAGR of 14.3%. In present scenario people are exposed to various harmful conditions which are affecting them through cancer and immunotherapy drugs are helping the people out. Rising cancer therapies coupled with lesser side effects are the factors provoking the market demand. Moreover high prevalence of lifestyle diseases are sustaining the market growth. However, high cost of therapy drugs is major factor restraining the market. 

Monoclonal antibodies is accounted for largest market share while Checkpoint inhibitors is estimated to be the fastest growing segment on account of its less effect to normal cells compared to ordinary therapeutics. North America commanded the largest market share followed by Europe owing to large government funding in cancer techniques and R&D. Quick drug approvals is also a major factor helping the regional growth.              

Some of the key players of the Immunotherapy Drugs market include Aduro BioTech Inc, Agenus Inc, Amgen Inc., Bavarian Nordic A/S, Bellicum Pharmaceuticals Inc, Biogen Idec Inc, Bristol-Myers Squibb Company, Celgene Corporation, DenDrit Biotech USA, ELI Lilly and Company, F. Hoffmann-La Roche Ag, Galena Biopharma Inc, Genentech Inc, Glaxosmithkline Plc, Merck & Co., Inc., NewLink Genetics Corp., Novartis International Ag, Oxford BioTherapeutics Ltd., Seattle Genetics, Inc. and Spectrum Pharmaceuticals, Inc..   

Drug Types Covered:
• Checkpoint Inhibitors
• Interferons
• Interleukins
• Monoclonal Antibodies
• Vaccines  

Applications Covered:
• Blood Cancer
• Breast Cancer
• Cervical Cancer
• Gastric Cancer
• Glioblastoma
• Lung Cancer
• Melanoma
• Prostate Cancer  

Regions Covered:
• North America
o US
o Canada
o Mexico
• Europe
o Germany
o France
o Italy
o UK 
o Spain     
o Rest of Europe 
• Asia Pacific
o Japan       
o China       
o India       
o Australia       
o New Zealand      
o Rest of Asia Pacific      
• Rest of the World
o Middle East
o Brazil
o Argentina
o South Africa
o Egypt

What our report offers:
- Market share assessments for the regional and country level segments
- Market share analysis of the top industry players
- Strategic recommendations for the new entrants
- Market forecasts for a minimum of 7 years of all the mentioned segments, sub segments and the regional markets
- Market Trends (Drivers, Constraints, Opportunities, Threats, Challenges, Investment Opportunities, and recommendations)
- Strategic recommendations in key business segments based on the market estimations
- Competitive landscaping mapping the key common trends
- Company profiling with detailed strategies, financials, and recent developments
- Supply chain trends mapping the latest technological advancements

 1 Executive Summary     
       
2 Preface    
  
 2.1 Abstract     
 2.2 Stake Holders    
 2.3 Research Scope    
 2.4 Research Methodology   
  2.4.1 Data Mining   
  2.4.2 Data Analysis   
  2.4.3 Data Validation   
  2.4.4 Research Approach   
 2.5 Research Sources    
  2.5.1 Primary Research Sources  
  2.5.2 Secondary Research Sources  
  2.5.3 Assumptions   
       
3 Market Trend Analysis    
 3.1 Introduction    
 3.2 Drivers     
 3.3 Restraints     
 3.4 Opportunities    
 3.5 Threats     
 3.6 Product Analysis    
 3.7 Application Analysis    
 3.8 Emerging markets    
       
4 Porters Five Force Analysis    
 4.1 Bargaining power of suppliers   
 4.2 Bargaining power of buyers   
 4.3 Threat of substitutes    
 4.4 Threat of new entrants   
 4.5 Competitive rivalry    
       
5 Global Immunotherapy Drugs, By Type of Drugs  
 5.1 Introduction    
 5.2 Checkpoint Inhibitors   
 5.3 Interferons     
 5.4 Interleukins     
 5.5 Monoclonal Antibodies    
 5.6 Vaccines      
       
6 Global Immunotherapy Drugs, By Application  
 6.1 Introduction    
 6.2 Blood Cancer    
 6.3 Breast Cancer    
 6.4 Cervical Cancer    
 6.5 Gastric Cancer    
 6.6 Glioblastoma    
 6.7 Lung Cancer    
 6.8 Melanoma    
 6.9 Prostate Cancer    
       
7 Global Immunotherapy Drugs market, By Geography 

 7.1 North America    
  7.1.1 US    
  7.1.2 Canada    
  7.1.3 Mexico    
 7.2 Europe     
  7.2.1 Germany    
  7.2.2 France    
  7.2.3 Italy    
  7.2.4 UK    
  7.2.5 Spain    
  7.2.6 Rest of Europe   
 7.3 Asia Pacific    
  7.3.1 Japan    
  7.3.2 China    
  7.3.3 India    
  7.3.4 Australia    
  7.3.5 New Zealand   
  7.3.6 Rest of Asia Pacific   
 7.4 Rest of the World    
  7.4.1 Middle East   
  7.4.2 Brazil    
  7.4.3 Argentina    
  7.4.4 South Africa   
  7.4.5 Egypt    
       
8 Key Developments     
 8.1 Agreements, Partnerships, Collaborations and Joint Ventures
 8.2 Acquisitions & Mergers   
 8.3 New Product Launch    
 8.4 Expansions    
 8.5 Other Key Strategies    
       
9 Company Profiling     
 9.1 Aduro BioTech Inc    
 9.2 Agenus Inc    
 9.3 Amgen Inc.     
 9.4 Bavarian Nordic A/S    
 9.5 Bellicum Pharmaceuticals Inc   
 9.6 Biogen Idec Inc    
 9.7 Bristol-Myers Squibb Company   
 9.8 Celgene Corporation    
 9.9 DenDrit Biotech USA    
 9.10 ELI Lilly and Company    
 9.11 F. Hoffmann-La Roche Ag    
 9.12 Galena Biopharma Inc   
 9.13 Genentech Inc    
 9.14 Glaxosmithkline Plc     
 9.15 Merck & Co., Inc.     
 9.16 NewLink Genetics Corp.   
 9.17 Novartis International Ag    
 9.18 Oxford BioTherapeutics Ltd.   
 9.19 Seattle Genetics, Inc.    
 9.20 Spectrum Pharmaceuticals, Inc.   


List Of Tables      
1 Global Immunotherapy Drugs market, By Region (2013-2022) ($MN)
2 Global Immunotherapy Drugs market, By Type of Drugs (2013-2022) ($MN)
3 Global Immunotherapy Drugs market, By Checkpoint Inhibitors (2013-2022) ($MN)
4 Global Immunotherapy Drugs market, By Interferons (2013-2022) ($MN)
5 Global Immunotherapy Drugs market, By (2013-2022) Interleukins ($MN)
6 Global Immunotherapy Drugs market, By Monoclonal Antibodies (2013-2022) ($MN)
7 Global Immunotherapy Drugs market, By Vaccines (2013-2022) ($MN)
8 Global Immunotherapy Drugs market, By Application (2013-2022) ($MN)
9 Global Immunotherapy Drugs market, By Blood Cancer (2013-2022) ($MN)
10 Global Immunotherapy Drugs market, By Breast Cancer (2013-2022) ($MN)
11 Global Immunotherapy Drugs market, By Cervical Cancer (2013-2022) ($MN)
12 Global Immunotherapy Drugs market, By Gastric Cancer (2013-2022) ($MN)
13 Global Immunotherapy Drugs market, By Glioblastoma (2013-2022) ($MN)
14 Global Immunotherapy Drugs market, By Lung Cancer (2013-2022) ($MN)
15 Global Immunotherapy Drugs market, By Melanoma (2013-2022) ($MN)
16 Global Immunotherapy Drugs market, By Prostate Cancer (2013-2022) ($MN)
17 North America Immunotherapy Drugs market, By Country (2013-2022) ($MN)
18 North America Immunotherapy Drugs market, By Type of Drugs (2013-2022) ($MN)
19 North America Immunotherapy Drugs market, By Checkpoint Inhibitors (2013-2022) ($MN)
20 North America Immunotherapy Drugs market, By Interferons (2013-2022) ($MN)
21 North America Immunotherapy Drugs market, By (2013-2022) Interleukins ($MN)
22 North America Immunotherapy Drugs market, By Monoclonal Antibodies (2013-2022) ($MN)
23 North America Immunotherapy Drugs market, By Vaccines (2013-2022) ($MN)
24 North America Immunotherapy Drugs market, By Application (2013-2022) ($MN)
25 North America Immunotherapy Drugs market, By Blood Cancer (2013-2022) ($MN)
26 North America Immunotherapy Drugs market, By Breast Cancer (2013-2022) ($MN)
27 North America Immunotherapy Drugs market, By Cervical Cancer (2013-2022) ($MN)
28 North America Immunotherapy Drugs market, By Gastric Cancer (2013-2022) ($MN)
29 North America Immunotherapy Drugs market, By Glioblastoma (2013-2022) ($MN)
30 North America Immunotherapy Drugs market, By Lung Cancer (2013-2022) ($MN)
31 North America Immunotherapy Drugs market, By Melanoma (2013-2022) ($MN)
32 North America Immunotherapy Drugs market, By Prostate Cancer (2013-2022) ($MN)
33 Europe Immunotherapy Drugs market, By Country (2013-2022) ($MN)
34 Europe Immunotherapy Drugs market, By Type of Drugs (2013-2022) ($MN)
35 Europe Immunotherapy Drugs market, By Checkpoint Inhibitors (2013-2022) ($MN)
36 Europe Immunotherapy Drugs market, By Interferons (2013-2022) ($MN)
37 Europe Immunotherapy Drugs market, By (2013-2022) Interleukins ($MN)
38 Europe Immunotherapy Drugs market, By Monoclonal Antibodies (2013-2022) ($MN)
39 Europe Immunotherapy Drugs market, By Vaccines (2013-2022) ($MN)
40 Europe Immunotherapy Drugs market, By Application (2013-2022) ($MN)
41 Europe Immunotherapy Drugs market, By Blood Cancer (2013-2022) ($MN)
42 Europe Immunotherapy Drugs market, By Breast Cancer (2013-2022) ($MN)
43 Europe Immunotherapy Drugs market, By Cervical Cancer (2013-2022) ($MN)
44 Europe Immunotherapy Drugs market, By Gastric Cancer (2013-2022) ($MN)
45 Europe Immunotherapy Drugs market, By Glioblastoma (2013-2022) ($MN)
46 Europe Immunotherapy Drugs market, By Lung Cancer (2013-2022) ($MN)
47 Europe Immunotherapy Drugs market, By Melanoma (2013-2022) ($MN)
48 Europe Immunotherapy Drugs market, By Prostate Cancer (2013-2022) ($MN)
49 Asia Pacific Immunotherapy Drugs market, By Country (2013-2022) ($MN)
50 Asia Pacific Immunotherapy Drugs market, By Type of Drugs (2013-2022) ($MN)
51 Asia Pacific Immunotherapy Drugs market, By Checkpoint Inhibitors (2013-2022) ($MN)
52 Asia Pacific Immunotherapy Drugs market, By Interferons (2013-2022) ($MN)
53 Asia Pacific Immunotherapy Drugs market, By (2013-2022) Interleukins ($MN)
54 Asia Pacific Immunotherapy Drugs market, By Monoclonal Antibodies (2013-2022) ($MN)
55 Asia Pacific Immunotherapy Drugs market, By Vaccines (2013-2022) ($MN)
56 Asia Pacific Immunotherapy Drugs market, By Application (2013-2022) ($MN)
57 Asia Pacific Immunotherapy Drugs market, By Blood Cancer (2013-2022) ($MN)
58 Asia Pacific Immunotherapy Drugs market, By Breast Cancer (2013-2022) ($MN)
59 Asia Pacific Immunotherapy Drugs market, By Cervical Cancer (2013-2022) ($MN)
60 Asia Pacific Immunotherapy Drugs market, By Gastric Cancer (2013-2022) ($MN)
61 Asia Pacific Immunotherapy Drugs market, By Glioblastoma (2013-2022) ($MN)
62 Asia Pacific Immunotherapy Drugs market, By Lung Cancer (2013-2022) ($MN)
63 Asia Pacific Immunotherapy Drugs market, By Melanoma (2013-2022) ($MN)
64 Asia Pacific Immunotherapy Drugs market, By Prostate Cancer (2013-2022) ($MN)
65 RoW Immunotherapy Drugs market, By Country (2013-2022) ($MN)
66 RoW Immunotherapy Drugs market, By Type of Drugs (2013-2022) ($MN)
67 RoW Immunotherapy Drugs market, By Checkpoint Inhibitors (2013-2022) ($MN)
68 RoW Immunotherapy Drugs market, By Interferons (2013-2022) ($MN)
69 RoW Immunotherapy Drugs market, By (2013-2022) Interleukins ($MN)
70 RoW Immunotherapy Drugs market, By Monoclonal Antibodies (2013-2022) ($MN)
71 RoW Immunotherapy Drugs market, By Vaccines (2013-2022) ($MN)
72 RoW Immunotherapy Drugs market, By Application (2013-2022) ($MN)
73 RoW Immunotherapy Drugs market, By Blood Cancer (2013-2022) ($MN)
74 RoW Immunotherapy Drugs market, By Breast Cancer (2013-2022) ($MN)
75 RoW Immunotherapy Drugs market, By Cervical Cancer (2013-2022) ($MN)
76 RoW Immunotherapy Drugs market, By Gastric Cancer (2013-2022) ($MN)
77 RoW Immunotherapy Drugs market, By Glioblastoma (2013-2022) ($MN)
78 RoW Immunotherapy Drugs market, By Lung Cancer (2013-2022) ($MN)
79 RoW Immunotherapy Drugs market, By Melanoma (2013-2022) ($MN)
80 RoW Immunotherapy Drugs market, By Prostate Cancer (2013-2022) ($MN)   

1. What do I do if I have a query on this report?
In case of any queries regarding this report, you can contact the customer service by filing the “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
2. Is the sample available for this report? Can I request the sample with my specific requirements?
Yes, the samples are available for all the published reports. You can request them by filling the “Request Sample” option available in this page.
Yes, you can request a sample with your specific requirements. All the customized samples will be provided as per the requirement with the real data masked.
3. Format of the report?
All our reports are available in Digital PDF format. In case if you require them in any other formats, such as PPT, Excel etc you can submit a request through “Inquiry Before Buy” form available on the right hand side. You may also contact us through email: [email protected] or phone: +1-301-202-5929
4. Services prior to purchase and after purchase?
We offer a free 15% customization with every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.
5. License Type and Delivery?
We have 3 different licensing options available in electronic format.
  • Single User Licence: Allows one person, typically the buyer, to have access to the ordered product. The ordered product cannot be distributed to anyone else.
  • 2-5 User Licence: Allows the ordered product to be shared among a maximum of 5 people within your organisation.
  • Corporate License: Allows the product to be shared among all employees of your organisation regardless of their geographical location.
All our reports are typically be emailed to you as an attachment
6. Purchase procedure and Invoicing?
To order any available report you need to register on our website. The payment can be made either through CCAvenue or PayPal payments gateways which accept all international cards
7. Post sale support?
We extend our support to 6 months post sale. A post sale customization is also provided to cover your unmet needs in the report.

We provide a free 15% customization on every purchase. This requirement can be fulfilled for both pre and post sale. You may send your customization requirements through email at [email protected] or call us on +1-301-202-5929.

Note: This customization is absolutely free until it falls under the 15% bracket. If your requirement exceeds this a feasibility check will be performed. Post that, a quote will be provided along with the timelines.

Select License Type

Single User License (PDF)

 

2 - 5 User License (PDF)

 

Site License (PDF)

 

Corporate License (PDF)

 

Have a Question?


Know our Methodology

WHY CHOOSE US ?

Assured Quality

Best in class reports with high standard of research integrity

24X7 Research Support

Continuous support to ensure the best customer experience.

Free Customization

Adding more values to your product of interest.

Safe & Secure Access

Providing a secured environment for all online transactions.

Trusted by 600+ Brands

Serving the most reputed brands across the world.

Testimonials